However, the lower dose of semaglutide used and a focus on patient-reported outcomes rather than on cardiovascular events are limitations of STEP-HFpEF DM
The pattern of symptom improvement can help confirm that your body is adjusting appropriately to lower medication levels
As a health writer who follows clinical nutrition research, I was skeptical
Once she reached her sixties, she found it just about impossible to lose the extra 30 pounds (lb) she'd gained
The mechanism of action involves several key effects: Enhanced insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood glucose levels without causing hypoglycaemia when glucose levels are normal Suppression of glucagon release from pancreatic alpha cells, reducing hepatic glucose production Delayed gastric emptying , which slows the rate at which food leaves the stomach and enters the small intestine Increased satiety through central nervous system effects, leading to reduced appetite and food intake The delayed gastric emptying effect is particularly relevant in the perioperative setting
Future perspectives In summary, the cardiovascular safety of all currently marketed GLP-1 RAs has been thoroughly established in large CVOTs (Sattar et al., 2021), of which some also suggested a substantial cardioprotective benefit